My watch list
my.bionity.com  
Login  

8 Newest Market Studies about the topic adult stem cells

rss

Fibrocell Sciences, Inc. (FCSC) - Financial and Strategic SWOT Analysis Review

Fibrocell Sciences, Inc. (FCSC) - Financial and Strategic SWOT Analysis Review Summary Fibrocell Science, Inc. ( FCSI) is an autologous cellular therapeutic company. FCSI is focused on developing autologous cell therapies for aesthetic, medical and scientific applications. These therapies are ...

more

RNL BIO Co., Ltd. (003190) - Financial and Strategic SWOT Analysis Review

RNL BIO Co., Ltd. (RNL BIO) is a publically held biotechnology company. The company is principally engaged in the development and manufacture of stem cell therapy products. RNL BIO offers products in two categories endocrine remedies which includes anti diabetes mellitus, growth promotion and ...

more

TMC Life Sciences Berhad (TMCLIFE) - Financial and Strategic SWOT Analysis Review

TMC Life Sciences Berhad (TMC Life) is a publicly held healthcare company engaged in the provision of specialist healthcare services through its subsidiaries. The company has four subsidiaries. TMC Fertility Centre engages in the provision of fertility services; Tropicana Medical Centre (M) Sdn ...

more

Pluristem Therapeutics Inc. (PSTI) - Financial and Strategic SWOT Analysis Review

Pluristem Therapeutics Inc. (Pluristem) is a bio-therapeutics company that is engaged in the development and commercialization of cell therapy production technologies and products. It mainly focuses on commercialization of non-personalized (allogeneic) cell therapy products for the treatment of ...

more

NeoStem, Inc. (NBS) - Financial and Strategic SWOT Analysis Review

NeoStem, Inc. (NeoStem), is a US based company acts as a adult stem cell bank. It is formerly known as Phase III Medical, Inc. The company is a publicly traded company, engaged in adult stem cell collection and banking services to the general adult population. NeoStem provides adult stem cell ...

more

Opexa Therapeutics, Inc. (OPXA) - Financial and Strategic SWOT Analysis Review

Opexa Therapeutics, Inc. (Opexa) is a publicly held pharmaceutical company. It is engaged in the development of autologous cellular therapies which can treat several illnesses like multiple sclerosis, rheumatoid arthritis, diabetes and heart failure. The company's product pipeline includes, ...

more

Spine Smith, LP - Strategic SWOT Analysis Review

Spine Smith, LP (SpineSmith) is a medical device company, which is engaged in the design, manufacture and marketing of surgical implants for the spinal and orthopaedic markets. It develops and markets synthetic implants and biologics used in surgical fixation, correction and tissue regeneration ...

more

SYGNIS Pharma AG (LIOK) - Financial and Strategic SWOT Analysis Review

SYGNIS Pharma AG (SYGNIS Pharma) is a Germany based pharmaceutical company. The company engates in research, development and marketing of therapies for the treatment of neuro-degenerative diseases. The company develops drugs for the treatment of conditions of the central nervous system, such as ...

more

Page 1 From 1
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE